Decline in approvals challenges drug firms
A decline in U.S. drug approvals, spurred by an "increased conservatism" on safety issues by the Food and Drug Administration, raises the stakes in 2011 for the nation's largest drugmakers.

Pharmaceutical Sector: Does The FDA Help Or Harm?
It is difficult to overstate the importance of the FDA to companies in the pharmaceutical, medical device, biotechnology and diagnostics industries. In short, the FDA effectively gets to decide who is even allowed to compete in the market.

Approvals Of New Drugs Down In 2010 Vs 2009, 2008
Approvals Of New Drugs Down In 2010 Vs 2009, 2008